MOH Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, IPB, CAMS-Fondation Mérieux, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
PLoS One. 2012;7(6):e39644. doi: 10.1371/journal.pone.0039644. Epub 2012 Jun 22.
Four species of human bocaviruses (HBoV1-4) have been identified based on phylogenetic analysis since its first report in 2005. HBoV1 has been associated with respiratory disease, whereas HBoV2-4 are mainly detected in enteric infections. Although the prevalence of HBoVs in humans has been studied in some regions, it has not been well addressed globally.
METHODOLOGY/PRINCIPAL FINDINGS: Cross-reactivity of anti-VP2 antibodies was detected between HBoV1, 2, 3, and 4 in mouse and human serum. The prevalence of specific anti-VP2 IgG antibodies against HBoV1-4 was determined in different age groups of healthy individuals aged 0-70 years old in Beijing, China, using a competition ELISA assay based on virus-like particles of HBoV1-4. The seroprevalence of HBoV1-4 was 50%, 36.9%, 28.7%, and 0.8%, respectively, in children aged 0-14 years (n = 244); whereas the seroprevalence of HBoV1-4 was 66.9%, 49.3%, 38.7% and 1.4%, respectively, in healthy adults (≥ 15 years old; n = 142). The seropositive rate of HBoV1 was higher than that of HBoV2, HBoV3, and HBoV4 in individuals older than 0.5 years. Furthermore, IgG seroconversion of HBoV1 (10/31, 32.3%), HBoV2 (8/31, 25.8%), and HBoV3 (2/31, 6.5%) was found in paired sera collected from children with respiratory tract infections who were positive for HBoV1 according to PCR analysis.
CONCLUSIONS/SIGNIFICANCE: Our data indicate that HBoV1 is more prevalent than HBoV2, HBoV3, and HBoV4 in the population we sampled in Beijing, China, suggesting that HBoV species may play differential roles in disease.
自 2005 年首次报道以来,基于系统发生分析已确定了四种人类博卡病毒(HBoV1-4)。HBoV1 与呼吸道疾病有关,而 HBoV2-4 主要在肠道感染中检测到。尽管在一些地区已经研究了 HBoVs 在人类中的流行情况,但在全球范围内尚未得到很好的解决。
方法/主要发现:在小鼠和人血清中检测到抗 VP2 抗体与 HBoV1、2、3 和 4 之间的交叉反应。使用基于 HBoV1-4 病毒样颗粒的竞争 ELISA 检测,在中国北京不同年龄组的 0-70 岁健康个体中,确定了针对 HBoV1-4 的特异性抗 VP2 IgG 抗体的流行率。0-14 岁儿童(n = 244)的 HBoV1-4 血清阳性率分别为 50%、36.9%、28.7%和 0.8%;而健康成年人(≥15 岁;n = 142)的 HBoV1-4 血清阳性率分别为 66.9%、49.3%、38.7%和 1.4%。年龄大于 0.5 岁的个体中,HBoV1 的血清阳性率高于 HBoV2、HBoV3 和 HBoV4。此外,在根据 PCR 分析 HBoV1 阳性的呼吸道感染患儿的配对血清中发现了 HBoV1(10/31,32.3%)、HBoV2(8/31,25.8%)和 HBoV3(2/31,6.5%)的 IgG 血清转换。
结论/意义:我们的数据表明,在中国北京,我们抽样人群中 HBoV1 的流行率高于 HBoV2、HBoV3 和 HBoV4,表明 HBoV 物种在疾病中可能发挥不同的作用。